Phase II Study of RAD001 Monotherapy in Patients With Unresectable Adenoid Cystic Carcinoma

被引：0
|
作者：
Kim, D. [1 ]
Shin, S. [2 ]
Kang, J. [3 ]
Cho, B. [4 ]
Kim, H. [5 ]
Jung, J. [6 ]
Park, K. [7 ]
Kwon, J. [8 ]
Hang, J. [9 ]
Bang, Y. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[2] Kosin Univ, Gospel Hosp, Dept Internal Med, Pusan, South Korea
[3] Catholic Univ, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea
[4] Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea
[5] Vet Hosp, Dept Internal Med, Seoul, South Korea
[6] Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea
[7] Keimyung Univ, Dept Internal Med, Dongsan Med Ctr, Taegu, South Korea
[8] Hallym Univ, Med Ctr, Dept Internal Med, Seoul, South Korea
[9] Natl Canc Ctr, Ctr Lung Canc, Ilsan, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72144-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S544 / S544
页数：1
相关论文
共 50 条
  • [1] A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma
    Kim, Dong-Wan
    Oh, Do-Youn
    Shin, Seong Hoon
    Kang, Jin Hyoung
    Cho, Byoung Chul
    Chung, Joo-Seop
    Kim, HyeJin
    Park, Keon Uk
    Kwon, Jung Hye
    Han, Ji-Youn
    Kim, Mi-Jung
    Bang, Yung-Jue
    BMC CANCER, 2014, 14
  • [2] A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma
    Dong-Wan Kim
    Do-Youn Oh
    Seong Hoon Shin
    Jin Hyoung Kang
    Byoung Chul Cho
    Joo-Seop Chung
    HyeJin Kim
    Keon Uk Park
    Jung Hye Kwon
    Ji-Youn Han
    Mi-Jung Kim
    Yung-Jue Bang
    BMC Cancer, 14
  • [3] Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma
    Keam, Bhumsuk
    Kim, Sung-Bae
    Shin, Seong Hoon
    Cho, Byoung Chul
    Lee, Keun-Wook
    Kim, Min Kyoung
    Yun, Hwan-Jung
    Lee, Se-Hoon
    Yoon, Dok Hyun
    Bang, Yung-Jue
    CANCER, 2015, 121 (15) : 2612 - 2617
  • [4] Phase II study of RAD001 in previously treated patients with metastatic pancreatic cancer
    Wolpin, B. M.
    Hezel, A. F.
    Ryan, D. P.
    Abrams, T. A.
    Meyerhardt, J. A.
    Blaszkowsky, L. S.
    Clark, J. W.
    Allen, B.
    Regan, E. M.
    Fuchs, C. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC)
    Jac, J.
    Giessinger, S.
    Khan, M.
    Willis, J.
    Chiang, S.
    Amato, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC).
    Amato, R. J.
    Misellati, A.
    Khan, M.
    Chiang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 224S - 224S
  • [7] Phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium
    Milowsky, M. I.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Trout, A.
    Flaherty, A.
    Gerst, S.
    Bajorin, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [8] A phase II trial of RAD001 in patients (PTS) with metastatic renal cell carcinoma (MRCC)
    Amato, R.
    Jac, J.
    Giessinger, S.
    Khan, M.
    Willis, J.
    Chiang, S.
    CANCER INVESTIGATION, 2007, 25 : 20 - 21
  • [9] Phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium
    Milowsky, M. I.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I.
    Flaherty, A.
    Tickoo, S.
    Al-Ahmadie, H.
    Bajorin, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Phase II study of bevacizumab and everolimus (RAD001) in the treatment of advanced renal cell carcinoma (RCC)
    Whorf, R. C.
    Hainsworth, J. D.
    Spigel, D. R.
    Yardley, D. A.
    Burris, H. A., III
    Waterhouse, D. M.
    Vazquez, E. R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345